AIM
EW icon

AXA Investment Managers’s Edwards Lifesciences EW Stock Holding History

AXA Investment Managers’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$52.4M Buy
+673,746
New +$52.6M 0.14% 138

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

AXA Investment Managers's EW Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Edwards Lifesciences (EW) in Q3 2025: 673,746 shares worth $52.4M. The stake represents 0.14% of the portfolio and ranks #138 among its holdings.

1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • AXA Investment Managers held 673,746 shares of Edwards Lifesciences worth $52.4M as of Q3 2025.
  • Edwards Lifesciences was a new AXA Investment Managers position in Q3 2025.
  • Edwards Lifesciences made up 0.14% of AXA Investment Managers's portfolio in Q3 2025, its #138 holding.
  • 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.